Paclitaxel-coated Balloon for Treatment of De-novo Non-complex Coronary Artery Lesions
Paclitaxel-coated Balloon for the Treatment of De-novo Non-complex Coronary Artery Lesions: an Open-label, Multicentre, Randomised, Non-inferiority Trial
Sponsor: Xijing Hospital
Listed as NCT04561739, this NA trial focuses on Coronary Artery Disease and De Novo Stenosis and remains ongoing. Sponsored by Xijing Hospital, it has been updated 9 times since 2021, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Apr 2024 — Jul 2024 [monthly]
Active Not Recruiting NA
-
Nov 2023 — Apr 2024 [monthly]
Active Not Recruiting NA
-
May 2023 — Nov 2023 [monthly]
Active Not Recruiting NA
▶ Show 4 earlier versions
-
Sep 2022 — May 2023 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2021 — Sep 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Not Yet Recruiting NA
-
Oct 2020 — Jan 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Xijing Hospital
For direct contact, visit the study record on ClinicalTrials.gov .